Location History:
- Branchburg, NJ (US) (2008 - 2013)
- Perkasie, PA (US) (2018 - 2023)
Company Filing History:
10 out of 2,405 
6 out of 1,829 
2 out of 10 
Years Active: 2008-2025
Title: Inventor Manuel De Lera Ruiz: Pioneering Innovations in HIV Treatment
Introduction
Manuel De Lera Ruiz, a prolific inventor based in Branchburg, NJ, has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of HIV. With a remarkable portfolio of 17 patents, Ruiz stands out for his innovative approaches to developing effective antiviral compounds.
Latest Patents
Among his notable inventions are the phosphinic amide prodrugs of tenofovir, which feature compounds of specific formulas. These compounds are designed for the inhibition of HIV reverse transcriptase, presenting promising possibilities for both the prophylaxis and treatment of HIV infections. Additionally, Ruiz has developed antiviral benzyl-amine phosphodiamide compounds, which share similar applications in combating HIV and delaying the progression of AIDS. These compounds can be formulated into pharmaceutical compositions, potentially combined with other antiviral agents, immunomodulators, antibiotics, or vaccines to enhance their efficacy.
Career Highlights
Ruiz's career includes significant stints at prominent pharmaceutical companies such as Merck Sharp & Dohme Corporation and Schering Corporation. His expertise in drug formulation and development has led to groundbreaking innovations that directly address critical health challenges. His patents have paved the way for new therapies that are essential for patients battling HIV and AIDS.
Collaborations
Throughout his career, Manuel De Lera Ruiz has worked collaboratively with notable professionals in the field, including Kevin D McCormick and Robert G Aslanian. These partnerships have undoubtedly enriched his research and development efforts, fostering an environment of shared knowledge and innovation.
Conclusion
Manuel De Lera Ruiz exemplifies the spirit of innovation within the realm of pharmaceutical sciences. His extensive patent portfolio and commitment to advancing HIV treatment underscore the importance of diligent research and collaboration in developing life-saving therapies. As he continues to build upon his legacy, Ruiz remains a beacon of progress in the fight against HIV and AIDS.